top of page

Mental Health: A New FDA Approved Medication Spravato (Esketamine) Also Known as Ketamine...

Mental health has been gaining attention and recognition in recent years, and there have been several updates in the field. One of the most recent updates is the approval of a new medication to treat depression.

Psychotherapy and Psychedelic Assisted Therapy
Ketamine Treatment for Depression, Anxiety, PTSD, amongst other diagnoses...

In March 2021, the US Food and Drug Administration (FDA) approved a new medication called Spravato (esketamine) for the treatment of depression in adults who have not responded to other treatments. Spravato is a nasal spray that works by targeting a different pathway in the brain than traditional antidepressants, providing a new option for those who have not found relief from other treatments.

According to a press release by the FDA, Spravato has shown significant improvement in depression symptoms compared to a placebo in clinical trials. However, there are some potential side effects, including dissociation, sedation, and increased blood pressure, so the medication must be administered in a certified healthcare setting.

This update in mental health is significant because depression is a common mental health disorder that affects millions of people worldwide. For those who have not found relief from traditional treatments, Spravato provides a new option for managing their symptoms.


1. US Food and Drug Administration. FDA approves new nasal spray medication for treatment-resistant depression; March 5, 2021.

2. National Institute of Mental Health. Depression.

3. Mayo Clinic. Depression (major depressive disorder).


Noté 0 étoile sur 5.
Pas encore de note

Ajouter une note
bottom of page